Impact of FOXA1 Expression on the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer

被引：0
|
作者：
Yuichi Hisamatsu
Eriko Tokunaga
Nami Yamashita
Sayuri Akiyoshi
Satoko Okada
Yuichiro Nakashima
Shinichi Aishima
Masaru Morita
Yoshihiro Kakeji
Yoshihiko Maehara
机构：
[1] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
[2] Kyushu University,Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences
来源：
Annals of Surgical Oncology | 2012年 / 19卷
关键词：
Breast Cancer; Estrogen Receptor; Hormone Therapy; Progesterone Receptor; Ki67 Index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1145 / 1152
页数：7
相关论文
共 50 条
  • [41] Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer
    Lippman, Marc
    [J]. LANCET ONCOLOGY, 2019, 20 (03): : 312 - 313
  • [42] Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer
    Riseberg, David
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2015, 9 : 65 - 73
  • [43] A 2009 Update on the Treatment of Patients with Hormone Receptor-Positive Breast Cancer
    Cleator, Susan J.
    Ahamed, Eliyaz
    Coombes, R. Charles
    Palmieri, Carlo
    [J]. CLINICAL BREAST CANCER, 2009, 9 : S6 - S17
  • [44] FOXA1 expression in breast cancer - Correlation with luminal subtype A and survival
    Badve, Sunil
    Turbin, Dmitry
    Thorat, Mangesh A.
    Morimiya, Akira
    Nielsen, Torsten O.
    Perou, Charles M.
    Dunn, Sandi
    Huntsman, David G.
    Nakshatri, Harikrishna
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4415 - 4421
  • [45] Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
    Funda Meric-Bernstam
    Huiqin Chen
    Argun Akcakanat
    Kim-Anh Do
    Ana Lluch
    Bryan T Hennessy
    Gabriel N Hortobagyi
    Gordon B Mills
    Ana Maria Gonzalez-Angulo
    [J]. Breast Cancer Research, 14
  • [46] Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
    Meric-Bernstam, Funda
    Chen, Huiqin
    Akcakanat, Argun
    Do, Kim-Anh
    Lluch, Ana
    Hennessy, Bryan T.
    Hortobagyi, Gabriel N.
    Mills, Gordon B.
    Gonzalez-Angulo, Ana Maria
    [J]. BREAST CANCER RESEARCH, 2012, 14 (05)
  • [47] Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
    Meric-Bernstam, Funda
    Chen, Huiqin
    Akcakanat, Argun
    Kim-Anh Do
    Lluch, Ana
    Hennessy, Bryan
    Hortobagyi, Gabriel
    Mills, Gordon
    Gonzalez-Angulo, Ana
    [J]. CANCER RESEARCH, 2012, 72
  • [48] Prognosis of breast cancer as a result of late recurrence in hormone receptor-positive tumor.
    Kim, Hee Jeong
    Lee, Sae Byul
    Ko, Beom Seok
    Yu, Jong Han
    Lee, Jong Won
    Son, Byung Ho
    Ahn, Sei-Hyun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [49] The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer
    Park, Woong Ki
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Yu, Jonghan
    Ryu, Jai Min
    Chae, Byung Joo
    [J]. CANCERS, 2023, 15 (22)
  • [50] Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer
    Christgen, Matthias
    Gluz, Oleg
    Harbeck, Nadia
    Kates, Ronald E.
    Raap, Mieke
    Christgen, Henriette
    Clemens, Michael
    Malter, Wolfram
    Nuding, Benno
    Aktas, Bahriye
    Kuemmel, Sherko
    Reimer, Toralf
    Stefek, Andrea
    Krabisch, Petra
    Just, Marianne
    Augustin, Doris
    Graeser, Monika
    Baehner, Frederick
    Wuerstlein, Rachel
    Nitz, Ulrike
    Kreipe, Hans
    [J]. CANCER, 2020, 126 (22) : 4847 - 4858
12345